– USA, CA – HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the appointment of President and Board member, John Farquhar as President and CEO, effective March 1, 2022, succeeding Dr. John Stevens who will remain on the Board of Directors as Vice-Chair.
“The leadership transition comes at the right time as the company is at an important inflection point. I am confident that John Farquhar’s relentless focus on our patients and customers, proven leadership, and strong track record of operational excellence will enable the company to accelerate broader access to the AI-driven HeartFlow Analysis and introduce game-changing product innovations such as the PreRead anatomic assessment and Plaque technology,” said Board Chairman, BillWeldon, Chairman.
“Having worked closely with John Farquhar over the past seven months, I am confident that he is the right fit for this position,” said Dr. Stevens, Vice-Chair. “I’m so proud of all that HeartFlow has accomplished over the past 12 years and excited about what the future holds for our revolutionary precision technology as we enter this next stage of expansion. With new growth catalysts on the horizon, I look forward to further supporting the company in my role as Board Vice-Chair.”
About John Farquhar
Mr. Farquhar has more than 20 years of experience in key leadership roles, providing strategic oversight, driving outstanding performance, and delivering operational excellence. Before joining HeartFlow in August 2021 as COO, he served as VP and General Manager of Medtronic’s Aortic business. He also served in key leadership roles for Medtronic’s Cardiovascular and Diabetes Groups, including VP of the Americas region for the Insulin Pump and Continuous Glucose Monitoring business unit and VP for the Asia Pacific.
“I am honored to have the opportunity to lead the company at this exciting time of growth,” said Mr. Farquhar. “HeartFlow’s AI-driven technology offers a compelling value proposition for both clinicians and patients and is enhancing the care paradigm for patients with coronary artery disease. I look forward to working with our talented and passionate team as we continue to evolve our business and technology.”
Mr. Farquhar earned his BA from Duke University and his MBA from Northwestern’s Kellogg School of Management.
About HeartFlow
HeartFlow is the leader in revolutionizing precision heart care, uniquely combining human ingenuity with advanced technology. HeartFlow’s non-invasive HeartFlow FFRct Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRct Analysis is commercially available in the United States, UK, Canada, Europe, and Japan.
For more information: https://www.heartflow.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
